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doi:10.1016/j.gmbhs.2012.04.002Abstract To identify any biomarkers related to the migration of esophageal squamous cell
carcinoma (ESCC) cells, ESCC CE81T cells were used to establish the CE81T-1 subline, which
demonstrates increased migration activity after Transwell screening and microarray anal-
ysis. Among the differentially expressed genes, S100A9 was most downregulated, and
MAGED4, C8orf30A, and IL-8 were the most upregulated in CE81T-1 cells. The expression
of these four genes at the mRNA level was validated using the ESCC CE81T and KYSE cell
lines and clarified in ESCC specimens using real-time polymerase chain reaction. Among
60 pairs of ESCC specimens (normal and tumor specimens), the expression level of
S100A9 mRNA was significantly lower in the tumor sections in comparison with the normal
sections (pZ 0.0228). In contrast, the expression level of IL-8 mRNA was significantly higher
in the tumor sections in comparison with the normal sections (pZ 0.0061). Furthermore,
C8orf30A expression was significantly correlated with ESCC metastatic status (pZ 0.0358)
and associated with poorer survival (pZ 0.036), as determined by Kaplan-Meier analysis.
Functional studies revealed that S100A9 plays a suppressive role in the proliferation and
migration of ESCC cells through the overexpression of ectopic S100A9 and small interfering
RNA, as determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)t of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan 701,
du.tw (H.-S. Liu).
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Migration-related genes in ESCC 17and Transwell assays. Altogether, this study reveals that C8orf30A has the potential to be
used as a novel biomarker for the prognosis for ESCC metastasis and survival. Furthermore,
the IL-8 and S100A9 genes may have potential in ESCC diagnosis.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Esophageal cancer (EC) is the eighth most common cancer
in the world and is the ninth leading cause of cancer death
in Taiwan.1 EC is classified into two histological types:
esophageal squamous cell carcinoma (ESCC) and esopha-
geal adenocarcinoma (EA). These types show a variety of
geographic distributions.2 In Taiwan, there is an increasing
trend of the incidence of ESCC, but not EA.3 The prognosis
of ESCC is very poor and the 5-year survival rate is <10%.4
Accumulated evidence suggests that cyclin D1, p53,
E-cadherin, and vascular endothelial growth factor (VEGF)
can be used as independent predictors of the clinical
outcome of ESCC patients. In this study, we identified ESCC
migration-related genes by microarray analysis followed by
real-time polymerase chain reaction (PCR) validation and
clarified their roles in ESCC specimens.Materials and methods
The human ESCC cell lines CE81T, CE81T-1, CE81T-2,
KYSE150, KYSE510, KYSE70, and KYSE 170 were used in this
study. Human esophageal tissue specimens were obtained
from National Cheng Kung University Hospital (Tainan,
Taiwan). All patients provided informed consent before the
specimens were collected. Specific antibodies were used to
detect S100A9 expression by Western blotting. S100A9
protein expression in the ESCC specimens was detected
using immunohistochemical (IHC) staining. The mRNA
expression level of S100A9, IL-8, MAGED4, and C8orf30A
were measured using real-time with specific polymerase
chain reaction (PCR) primers. Migration of each ESCC cell
line was investigated using wound-healing and transwell
(Falcon, BD labware, Bedford, MA, USA) assays. The
Transwell assay consisted of upper and lower chambers that
were separated by a layer with an 8-mm pore size (Falcon,
BD Labware, Bedford, MA, USA). Cells (7.0 105 cells/
plate) were added to the upper chamber in 200 mL serum-
free Dulbecco’s Modified Eagle Medium (DMEM; Gibco BRL,
Gaithersburg, MD, USA), and 600 mL DMEM containing 10%
Fetal bovine serum (Gibco BRL, Gaithersburg, MD, USA) was
added to the lower chamber as the chemoattractant. The
cells were incubated at 37C in a 5% CO2 incubator over-
night. Uninvaded cells were removed using a scraper,
washed twice with phosphate buffered saline (PBS), and
then fixed in 1% formaldehyde for 15 minutes at room
temperature (RT). After fixation, the cells were washed
twice with PBS and then stained with 0.1% crystal violet
(Sigma-Aldrich, MD, USA) for 15 minutes at RT. Finally, the
stained cells were washed with PBS and air dried. Three
independent experiments were performed.Results
The CE81T-1 cell subline was established from parental
CE81T cells following Transwell screening in order to obtain
cells with higher migration abilities. The CE81T-1 cells were
more invasive than the CE81T cells. DNA microarray analysis
was performed to identify the differentially expressed
genes between these two cell lines. We found that S100A9
was the most downregulated, whereas MAGED4, C8orf30A,
and IL-8 were most upregulated in CE81T-1 cells with strong
migration activities.
Sixty pairwise ESCC specimens (tumor vs. normal), which
consisted of specimens obtained from 54 male and six
female patients, were analyzed in this study. Tumor status,
stage, and the patient survival rate were evaluated to
determine their correlation with mRNA deregulation of the
S100A9, MAGED4, C8orf30A, and IL-8 genes. Using the
log-rank test, we found that the expression levels of S100A9
and C8orf30A were negatively correlated with ESCC
tumorigenesis. In contrast, IL-8 was positively correlated
with ESCC tumorigenesis. Furthermore, the C8orf30A
expression level correlated with metastasis and the poorer
survival rate of ESCC patients.
CE81T-2 was another subline established fromCE81Tcells
by using the Transwell assay to screen for high-migration
cells. The migration capability of the CE81T-2 cells was
stronger than that of the CE81T and CE81T-1 cells. We also
determined that the order of the migration capabilities of
the four KYSE Japanese cell lines, from low to high, were
KYSE150, KYSE510, KYSE70, and KYSE170, as shown by the
results of the wound-healing analysis. The expression of
S100A9 was negatively correlated with the migration capa-
bility of the CE81T cells, which is consistent with the results
of the microarray analysis (-1.92-fold). This inverse rela-
tionship was also observed in the KYSE cell lines. The mRNA
expression levels ofMAGED4,C8orf30A, and S100A9, in terms
of pairwise comparisons with the CE81T-2 and CE81T cells as
measuredusing real-timePCR,were consistentwith thegene
expression profiles of the CE81T-1 and CE81T cells deter-
mined using microarray analysis.
The ESCC cell lines were divided into two groups: the first
group consisted of the CE81T and CE81T-2 cell lines and the
second group consisted of the KYSE150, KYSE510, KYSE70,
and KYSE170 cell lines. Our results show that the protein
expression of S100A9 in the CE81T-2, KYSE70, and KYSE170
cells with stronger migration capabilities was decreased
when compared with their slow-migration counterparts.
Taken together, both themRNA and protein expression levels
of S100A9 were negatively correlated with the mobility of
ESCC cells. In the same line of observations, the over-
expression or knockdown of the S100A9 gene in KYSE170 and
KYSE150 cells, respectively, significantly changed the
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gether, these results indicate that S100A9 is negatively
correlated with migration ability and cell proliferation.
Three ESCC tumor tissues from National Cheng Kung
University hospital were utilized for the evaluation of
S100A9 expression by IHC staining. The protein expression
of S100A9 was significantly higher in well-differentiated
tumors and adjacent tissues in comparison with poorly
differentiated tissues.
Discussion and conclusion
In this study, differential gene expression profiles related to
the mobility of the CE81T and CE81T-1 cell lines were
revealed using DNA microarray analysis. Four genesd
MAGED4, C8orf30A, IL-8, and S100A9ddemonstrated
deregulated mRNA expression in pairwise comparisons. To
validate the microarray results, the gene expression levels
of these four genes in the CE81T and KYSE cell lines with
different migration capabilities were evaluated using real-
time PCR. Our data show that C8orf30A and MAGED4 gene
expression levels were higher in CE81T-1 and CE81T-2 cells
in comparison with the CE81T parental cells, indicating that
the expression levels of these two genes are positively
correlated with cell migration, which is consistent with the
microarray results. The expression of S100A9 was lower in
CE81T-1 and -2 cells with stronger mobilities. The inverse
relationship between S100A9 expression and cell migration
was also demonstrated in the four ESCC KYSE cell lines.
Altogether, S100A9 plays a suppressive role in ESCC cancer
cell migration, further confirming the downregulation of
S100A9 that has been observed in other studies on ESCC.5e7
In contrast to S100A9, IL-8 was identified as being
overexpressed by the results of the DNA microarray. The
differential gene expression profiles of CE81T-2 and CE81T
were also screened using a customized microarray chip
that contained 100 cancer-related genes. IL-8 was consis-
tently overexpressed in CE81T-2 cells with high-migration
potential.
The deregulation of S100A9 and IL8 mRNA was further
confirmed in clinical ESCC specimens using real-time PCR.
Our data show that IL-8 was significantly overexpressed,
whereas S100A9 was significantly underexpressed, in tumor
sections in comparison with the adjacent normal tissues in
60 pairs of ESCC specimens. Because the the role of S100A9
has never been explored in ESCC specimens, we furtherdemonstrated the negative role of S100A9 has on cell
migration and proliferation by demonstrating the over-
expression and silencing of S100A9 expression. Using IHC
staining, we also revealed that the S100A9 protein is highly
expressed in well-differentiated tumors and adjacent
normal tissues, but not in the poorly differentiated tissues.
This result is consistent with the report by Luo et al.6
When comparing the clinical and pathogenic parameters
of the ESCC specimens in terms of the deregulation of the
four identified genes, C8orf30A was the only gene that
demonstrated a significant correlation with metastatic
status when we analyzed 53 ESCC patients (pZ 0.0358).
The expression of C8orf30Awas also significantly correlated
with the poorer survival rate of these patients (pZ 0.036),
suggesting that C8orf30A may be involved in metastasis and
has potential use as a prognostic marker.
In summary, the IL-8 and S100A9 genes may have
potential use in the diagnosis of ESCC. Moreover, C8orf30A
has the potential to be used as a novel biomarker of ESCC
metastasis and survival.References
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